Search

Search Constraints

You searched for: Author/Creator Tan, Fengwei

Search Results

1. Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer. Issue 4 (7th February 2019)

2. Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis. Issue 9 (September 2021)

3. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study. Issue 4 (April 2022)

5. PSC subtyping based on TTF‐1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies. Issue 5 (8th June 2022)

6. Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma. Issue 7 (21st June 2022)

7. External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer. (August 2022)

8. TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma. Issue 14 (24th May 2022)

9. Treatment outcomes of patients with tracheobronchial mucoepidermoid carcinoma compared with those with adenoid cystic carcinoma. Issue 10 (October 2020)